Search Results - mikhal+linetsky

1 Results Sort By:
A Novel Inhibitor for Advanced Glycation and Protein Crosslinking
­Dr. Ram Nagaraj and a team of researchers have developed a novel molecule, Carboxitin that significantly reduces crosslinking and Advanced Glycation Endproducts (AGEs) formation in eye tissues to reduce lens stiffness. This compound may have the potential to treat diabetic eye complications, cataracts, presbyopia, and age-related macular degeneration....
Published: 5/22/2023   |   Inventor(s): Ram Nagaraj, Mikhal Linetsky, Rooban Nahomi, Stefan Rakete
Disease Areas Ophthalmology
Category(s): Therapeutics
For inquiries, email: cuinnovations@cuanschutz.edu.     © 2024. All Rights Reserved. Powered by Inteum